NCT05972980 is a clinical trial of COVID-19 in Infections, sponsored by University of Turin, Italy.

Who is sponsoring NCT05972980?

NCT05972980 is sponsored by University of Turin, Italy.

What drugs are being tested in NCT05972980?

Interventions in NCT05972980: COVID-19.

What condition does NCT05972980 study?

NCT05972980 studies Infections, Critical Illness, Superinfection, Organ Failure, Multiple, Ventilator Associated Pneumonia, Septic Shock.

Is NCT05972980 still recruiting?

NCT05972980 is currently completed. Last updated 2 August 2023.

Last reviewed 2023-08-02 · How we verify

NCT05972980

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients

Completed Last updated 2 August 2023

What this trial tests

trial testing COVID-19 in Infections in 200 participants. Completed in 31 December 2022.

Timeline

1 January 2016

Primary endpoint
1 January 2016

31 December 2022

Quick facts

Lead sponsor	University of Turin, Italy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 January 2016
Primary completion	1 January 2016
Estimated completion	31 December 2022
Sites	1 location across Italy

Drugs / interventions tested

COVID-19 — full drug profile →

Conditions studied

Infections — all drugs for Infections →
Critical Illness — all drugs for Critical Illness →
Superinfection — all drugs for Superinfection →
Organ Failure, Multiple — all drugs for Organ Failure, Multiple →

Sponsor

University of Turin, Italy

Who can join

18 and older, any sex, with Infections or Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The COVID-19 pandemic has led to an increased incidence of ventilator-associated pneumonia (VAP) among critically ill patients. However, in a context of high prevalence of multidrug-resistant organisms (MDROs) there is a lack of direct comparison between the incidence of VAP in COVID-19 and non-COVID-19 cohorts. The investigators conducted a prospective, single-center cohort study comparing COVID-19 patients admitted to the intensive care unit (ICU) of the Città della Salute e della Scienza University Hospital in Turin, Italy, between March 2020 and December 2021 (COVID-19 group), with a historical cohort of ICU-mixed patients admitted between June 2016 and March 2018 (NON-COVID-19 group).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of COVID-19

Trials testing the same drug.

NCT07188116 — Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer · not yet recruiting
NCT05429047 — Priming of the NEonatal Immune System by Transfer of Maternal Immunity · unknown
NCT05481216 — HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV · completed
NCT05252442 — Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines · completed
NCT05222750 — Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England · completed

Other recruiting trials for Infections

Currently open trials in the same condition.

NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
NCT07189858 — Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada · NA · active not recruiting
NCT06426147 — L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients) · NA · recruiting
NCT06911658 — Infectious Complications After Esophagectomy · recruiting
NCT06145724 — EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1) · NA · recruiting

Other University of Turin, Italy trials

Trials by the same sponsor.

NCT06493188 — Low VS High-fidelity Interprofessional Simulation for ABG Skills Acquisition · NA · not yet recruiting
NCT07418489 — Biotics Intervention Oriented to Rescue From Environmental Pollution Inflammatory Responses · NA · enrolling by invitation
NCT07311291 — The Effect of Different Hemostatic Agents on Hemorrhage Control, Pain and Quality of Life After Endodontic Microsurgery. · NA · completed
NCT06904963 — Efficacy of Oral Hygiene Instructions Carried Out Using an Intra-oral Scanner · NA · completed
NCT07047261 — Efficacy of a Xanthan-based Chlorhexidine Gel in the Treatment of Peri-implant Mucositis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05972980 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Turin, Italy
Last refreshed: 2 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05972980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing